Form4insider filings, from the source

SEC Form 4 · accession 0001171843-15-001493

Sucampo Pharmaceuticals, Inc. · SCMP

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Mar 11, 2015
Accepted (ET)
Mar 18, 2015 · 9:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001365216

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Class A Common StockMar 11, 2015M4,800$4.41A4,800D
Class A Common StockMar 11, 2015S4,800$17.34D0D
Class A Common StockMar 11, 2015M4,500$4.41A4,500D
Class A Common StockMar 11, 2015S4,500$17.34D0D
Class A Common StockMar 11, 2015M20,000$7.71A20,000D
Class A Common StockMar 11, 2015S20,000$17.34D0D
Class A Common StockMar 11, 2015M20,000$8.62A20,000D
Class A Common StockMar 11, 2015S20,000$17.34D0D
Class A Common StockMar 11, 2015M16,666$6.80A16,666D
Class A Common StockMar 11, 2015S16,666$17.34D0D
Class A Common Stockholding———68,800IBy trust

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Employee Stock Option (right to buy)$4.41Mar 11, 2015M4,800DJan 15, 2015May 2, 2021Class A Common Stock4,80071,400D
Employee Stock Option (right to buy)$4.41Mar 11, 2015M4,500DMay 2, 2014May 2, 2021Class A Common Stock4,50066,900D
Employee Stock Option (right to buy)F1$7.71Mar 11, 2015M20,000D—May 25, 2022Class A Common Stock20,00046,900D
Employee Stock Option (right to buy)F2$8.62Mar 11, 2015M20,000D—May 22, 2023Class A Common Stock20,00026,900D
Employee Stock Option (right to buy)F3$6.80Mar 11, 2015M16,666D—May 9, 2024Class A Common Stock16,66610,234D

Explanation of responses